Walpar Nutritions Limited (NSE: WALPAR) is a Gandhinagar, Gujarat-based company in the Vitamins and Nutritional Supplements industry. With a market capitalisation of ₹25 Cr, it ranks #4,466 by market cap among the 6,189 Indian listed companies on FinBizNet, and #5 of 5 in Vitamins and Nutritional Supplements. At ₹26.10 (as of 26 Oct 2026), the share price is 48.4% below its 52-week high of ₹50.60 and 22.8% above its 52-week low of ₹21.25. The share price is down 40.1% over one year and down 25.1% over three months.
| Current Price | ₹26.10 |
|---|---|
| Market Cap | ₹25 Cr |
| NSE Symbol | WALPAR |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Vitamins and Nutritional Supplements |
| P/E Ratio | 9.9 |
| Return on Equity | 15.68% |
| Return on Assets | 5.35% |
| 52-Week Range | ₹21.25 – ₹50.60 |
| 1-Year Price Change | -40.1% |
| 3-Month Price Change | -25.1% |
| Beta (1Y) | -0.01 |
| Headquarters | Gandhinagar, Gujarat |
| Website | www.walparnutritions.com |
Walpar Nutritions Limited manufactures and trades pharmaceutical, nutraceutical, herbal, and ayurvedic commodities in India. The company offers G-Flora, a probiotic blend for gut health and immunity; Inosia-F, an inositol supplement; Inovam Plus, a multivitamin; Ironica-CR, controlled-release iron supplement; Myobest, muscle support formula; Ovality, ovarian health support; Ovanyx-F, a female reproductive health supplement; Ovacon-F, women's fertility support; PCOS Care Forte, a PCOS support; Procive-F, female fertility enhancement supplement; Procive-M, a male fertility enhancement supplement; Refitil-M, a male reproductive health support; Cranvilin, a cranberry extract; Drostility, a fertility support; and FTM Plus and Mancare Forte, a male health support formula. It also provides FTW Plus, a women's health support formula; Joint-CR, a joint care supplement; Mecowal, a vitamin B12 supplement for neurological health; Megorich omega-3 fatty acids for heart and brain health; Ni-1000, ni
1. Vitamins & Nutrition Products-This segment develops, manufactures, and commercializes nutraceutical, ayurvedic, cosmeceuticals, wellness, and food supplement products.
1. Vitamins & Nutrition Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Hexagon Nutrition Limited | ₹754 Cr | 19.9 | 16.26% | ₹104 Cr | — |
| Aayush Food And Herbs Ltd | ₹120 Cr | 30 | 38.75% | — | -67.8% |
| Sandu Pharmaceuticals Ltd. | ₹33 Cr | 18.6 | 4.13% | ₹16 Cr | -22.9% |
| Deccan Health Care Ltd | ₹28 Cr | 11.9 | 2.11% | ₹22 Cr | -19.8% |
| Walpar Nutritions Limited | ₹25 Cr | 9.9 | 15.68% | — | -40.1% |
Listed by market capitalisation. Ratios are shown for context only.
Walpar Nutritions Limited is trading at ₹26.10, with a market capitalisation of ₹25 Cr.
Walpar Nutritions Limited operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).
Walpar Nutritions Limited has a P/E of 9.9 and a return on equity of 15.68%.
Walpar Nutritions Limited is listed on the NSE under the symbol WALPAR.
Walpar Nutritions Limited's share price is down 40.1% over one year and down 25.1% over three months. Its 52-week range is ₹21.25 to ₹50.60.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.